Related Experiment Videos
The T and B cell repertoire of patients with rheumatoid arthritis
I Melchers1, H H Peter, H Eibel
1Clinical Research Unit, University Medical Center, Freiburg, Fed. Rep. Germany.
Scandinavian Journal of Rheumatology. Supplement
|January 1, 1995
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Association of ferritin autoantibodies with giant cell arteritis/polymyalgia rheumatica.
Annals of the rheumatic diseases·2012
[Genetic analysis in collagen vascular diseases].
Zeitschrift fur Rheumatologie·2011
How should impaired morning function in rheumatoid arthritis be treated?
Scandinavian journal of rheumatology. Supplement·2011
Morning stiffness and other patient-reported outcomes of rheumatoid arthritis in clinical practice.
Scandinavian journal of rheumatology. Supplement·2011
How should morning function in rheumatoid arthritis be assessed? Bibliographic study of current assessment.
Scandinavian journal of rheumatology. Supplement·2011
How much is a reduction in morning stiffness worth to patients with rheumatoid arthritis?
Scandinavian journal of rheumatology. Supplement·2011
Impact of impaired morning function on the lives and well-being of patients with rheumatoid arthritis.
Scandinavian journal of rheumatology. Supplement·2011
Morning symptoms in rheumatoid arthritis: a defining characteristic and marker of active disease.
Scandinavian journal of rheumatology. Supplement·2011
From oncogenesis to approval: the lentiviral gene therapy revolution in Wiskott-Aldrich syndrome.
Regenerative medicine·2026
Primary extranodal marginal zone lymphoma of gastric mucosa-associated lymphoid tissue in children: a case report and review of the literature.
Journal of medical case reports·2026
Beyond MYD88-only testing: MYD88/CD79B profiling improves molecular detection and MCD genotyping in VRL and CNS lymphomas.
Experimental hematology & oncology·2026
Geranylgeranylation is required for B-cell proliferation and plasma cell survival implications for autoimmune therapy.
Cellular & molecular immunology·2026
A microbiota-driven CCL25-CCR9 axis reprograms intestinal ILC2s in the distal small intestine to promote metabolic dysfunction in obesity.
Cellular and molecular gastroenterology and hepatology·2026